# Relaxed multi-module round-2 P1-S audit

> Date: 2026-06-21
> Scope: P1 concrete-module boundary follow-up focused on `ASD-0715`.
> Rule: only high-confidence changes supported by first-hand paper evidence, official project assets, or other authoritative first-hand sources are written back to the master list and Notes.

## 本轮结论

本轮关闭 1 条 `07 / 06` 边界记录：

| ID | Title short | Sources checked | Decision | Note action |
|---|---|---|---|---|
| `ASD-0715` | BioDisco | arXiv abstract / version page `2508.01285`; ar5iv full text `2508.01285v2`; official GitHub `yujingke/BioDisco`; official PyPI `biodisco`; TruthHypo official benchmark metadata cited in the paper | accepted `scientific_object_modules=07;06`; keep `primary_module_for_filing=07` | revised `Notes/07_Medical_and_Health_Sciences/Ke_2025_BioDisco.md` |

## Evidence summary

### `ASD-0715` BioDisco: Multi-agent hypothesis generation with dual-mode evidence, iterative feedback and temporal evaluation

- Agent evidence: the paper presents a multi-agent hypothesis-generation framework with planner, scientist, critic, literature retrieval, biomedical knowledge-graph evidence, and iterative feedback loops.
- `07` evidence: the paper is explicitly framed as biomedical hypothesis generation. The expert-evaluation domains are cardiovascular medicine and NSCLC immunotherapy, and the reported task framing repeatedly targets disease mechanisms, immune-therapy relevance, and therapeutic-target discovery.
- `06` evidence: the full text goes beyond generic biomedical framing and repeatedly reports recognizable life-science mechanism objects. The biomedical KG is explicitly described as containing genes, proteins, drugs, diseases, and biological pathways. The benchmark discussion includes chemical-gene, disease-gene, and gene-gene relations. The detailed cases and prompts also surface gene/protein/pathway/cell-state objects such as GPR153, CEBPB, YAP1, GSK3B, NRF1, CD7, vascular smooth muscle cells, macrophages, B-cell-mediated antibody production, and CD8+ T-cell exhaustion, alongside instructions to propose new biological mechanisms or interactions. The appendix/temporal-evaluation material also includes developmental and regeneration-style life-science objects such as gene regulation, wing discs, brain regeneration, and limb regeneration, pushing the record past a pure disease-only reading.
- Why the boundary is now closed: although all end-to-end examples remain embedded in disease and therapeutic contexts, the object evidence is no longer only medical-facing. The full text directly exposes genes, proteins, pathways, and cell-state mechanisms as reported hypothesis objects, which is sufficient for additional `06` coverage under the current relaxed rule.
- Accepted action: close the `07 / 06` boundary as `07;06`, while keeping `07` as the relaxed primary filing direction.

## Count update

Post-P1-S relaxed overlay counts increase only in module `06`:

| Scientific object module | Expanded assignment count |
|---|---:|
| `01` | 55 |
| `02` | 37 |
| `03` | 82 |
| `04` | 110 |
| `05` | 35 |
| `06` | 76 |
| `07` | 72 |
| `08` | 3 |
| `09` | 36 |
| `10` | 24 |
| `11` | 35 |

| Metric | Count |
|---|---:|
| Record-level confirmed included-and-classified count | 451 |
| Expanded module assignment count | 563 |
| Independent `01.04` general-method bucket count | 20 |

## Remaining uncertainty

- BioDisco is still a relatively medicine-heavy `07/06` crossover rather than a strong pure-`06` paper; future synthesis should present it that way.
- That said, the current first-hand evidence is already sufficient to land additional `06` coverage, so this record no longer needs to stay open in the round-2 boundary queue.
